Travere Therapeutics, Inc.
Extract: Charter Amendment (Plain English Desc) from a 8-K on 11/16/2020   Download
SEC Document
SEC Filing
Effective November 13, 2020, we changed our name from “Retrophin, Inc.” to “Travere Therapeutics, Inc.” by filing a certificate of amendment (“Certificate of Amendment”) to our Certificate of Incorporation with the Secretary of State of the State of Delaware.